Blood test may spot hidden heart risk in kidney patients

NCT ID NCT04950439

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether low levels of pyrophosphate, a natural substance that prevents mineral buildup, can predict artery hardening in people with moderate chronic kidney disease. Researchers will measure pyrophosphate in blood samples from 242 patients and track artery changes over three years. The goal is to find a simple way to identify those at highest risk for heart problems.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple blood test to identify kidney disease patients at high risk for artery hardening, allowing earlier intervention.
What could go wrong
This is an observational study, not a treatment trial. It only measures a possible link, so it cannot prove cause and effect or directly improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nice

    Nice, Alpes Maritimes, 06001, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.